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This study investigated the effect of administration of
α-lipoic acid (LA) on lipid metabolism in high fructose–
fed insulin-resistant rats. High-fructose feeding (60 g/100 g
diet) to normal rats resulted in a signiﬁcant increase in
the concentrations of cholesterol, triglycerides (TGs), free
fatty acids (FFAs), and phospholipids in plasma, liver, kid-
ney, and skeletal muscle. Reduced activities of lipopro-
tein lipase (LPL) and lecithin cholesterol acyl transferase
(LCAT) and increased activity of the lipogenic enzyme
hydroxymethylglutaryl–coenzyme A (HMG-CoA) reduc-
tase were observed in plasma and liver. High-density
lipoprotein cholesterol (HDL-C) was signiﬁcantly lowered
andverylow-densitylipoproteincholesterol(VLDL-C)and
low-density lipoprotein cholesterol (LDL-C) were signiﬁ-
cantly elevated. Treatment with LA (35 mg/kg body weight
intraperitoneal) reduced the effects of fructose. The rats
showed near-normal levels of lipid components on plasma
and tissues. Activities of key enzymes of lipid metabolism
were also restored to normal values. Cholesterol distribu-
tion in the plasma lipoproteins was normalized, resulting in
a favorable lipid proﬁle. This study demonstrates that LA
can alter lipid metabolism in fructose-fed insulin-resistant
rats and may have implications in the treatment of insulin
resistance.
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Feeding rats with high dosage of fructose (>60% of total
calories in diet) affects lipid metabolism and causes profound
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changes in plasma lipid proﬁle. Fructose elevates triglycerides
(TGs)andcholesterolinblood[1].Fructosefeedingevokessig-
niﬁcantalterationsparticularlyinliverTGmetabolismandisre-
ported to be atherogenic due to induction of lipogenic enzymes
in liver [2]. Lipid changes associated with fructose feeding are
documented to be secondary to the development of insulin re-
sistanceandlossofinvivoinsulinsensitivity[3].Lossofinsulin
action causes a shift in balance from oxidation to esteriﬁcation
offreefattyacids(FFAs),resultinginelevatedverylow-density
lipoprotein (VLDL) secretion [4].
α-Lipoic acid (LA) is a natural cofactor in dehydrogenase
complexessuchaspyruvatedehydrogenaseandα-ketoglutarate
dehydrogenase. It is a small molecule that can easily cross
the blood-brain barrier and has antioxidant properties [5]. LA
improves insulin sensitivity and is found to be useful in the
treatment of insulin resistance [6], LA has been prescribed for
diabetic complications, especially diabetic polyneuropathy, in
Germany for over 30 years [7]. LA inﬂuences lipid metabolism
in liver, kidney, and blood of renal stone–forming rat model
[8, 9]. However, there are no reports in the literature on
the effects of LA on lipid parameters in the insulin-resistant
state. Based on these observations, we designed a study
to investigate the effect of LA on plasma and tissue lipid
metabolism in fructose-fed insulin-resistant rats. The results
obtained are compared with those in untreated fructose-fed
rats.
MATERIALS AND METHODS
Animals and Diet
Male adult Wistar rats of body weight ranging from 150
to 170 g were obtained from the Department of Experimental
Medicine, Central Animal House, Rajah Muthiah Medical
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College, Annamalai Nagar. Rats were housed 2 per cage un-
der controlled conditions on a 12-hour light/12-hour dark cy-
cle. Animals received a standard pellet diet (Karnataka State
Agro Corporation, Agro Feeds Division, Bangalore, India) and
water ad libitum. The animals used in the present study were
treated under the principles and guidelines of the Ethical Com-
mittee of Animal Care of Annamalai University and in ac-
cordance with the Indian National Law on animal care and
use.
After acclimatization the animals were divided into the fol-
lowing 4 groups consisting of 6 rats each.
Group 1 (CON): Received control diet and water ad li-
bitum; 0.2 mL of saline was given
intraperitoneally.
Group 2 (FRU): Received a fructose-enriched diet and
water ad libitum; 0.2 mL of saline was
given intraperitoneally.
Group 3 (FRU + LA): Received fructose diet and adminis-
tered with lipoic acid (35 mg/kg body
weight [bw]) in saline by intraperi-
toneal injection.
Group 4 (CON + LA): Received the control diet and were
given lipoic acid (35 mg/kg bw) in
saline by intraperitoneal injection.
The composition of control diet and fructose diet are given
in Table 1. The diets were prepared fresh daily.
The animals were maintained in their respective groups for
20 days. At the end of 20 days, the rats were fasted overnight
TABLE 1
Composition of diet (g/100 g)
Ingredients Control diet High-fructose diet
Corn starch 60 —
Fructose — 60
Casein (fat free) 20 20
Methionine 0.7 0.7
Groundnut oil 5 5
Wheat bran 10.6 10.6
Salt mixturea 3.5 3.5
Vitamin mixtureb 0.2 0.2
aThe composition of mineral mix (g/kg): MgSO4·7H2O 30.5; NaCl
65.2; KCl 105.7; KH2PO4 200.2; 3MgCO3, Mg(OH)2·3H2O 38.8;
FeC6H5O7·5H2O 40.0; CaCO3 512.4; KI 0.8; NaF 0.9; CuSO4.5H2O
1.4; MnSO4 0.4, and CONH3 0.05.
bOnekilogramofvitaminmixcontainedthiaminemononitrate,3g;
riboﬂavin, 3 g; pyridoxine HCI, 3.5 g; nicotinamide, 15 g; d-calcium
pantothenate, 8 g; folic acid, 1 g; d-biotin, 0.1 g; cyanocobalamin, 5
mg; vitamin A acetate, 0.6 g; α-tocopherol acetate, 25 g; and choline
chloride, 10 g.
(12 hours) and were anesthetized using diethyl ether. Blood
samples were collected by sinocular puncture in heparinized
tubes and the animals were sacriﬁced by cervical disloca-
tion. Plasma was separated by centrifugation. Liver, kidney,
and skeletal muscle tissues were collected, washed in ice-cold
saline, homogenized in 0.1 M Tris–hydrochloric acid buffer,
pH 7.4, and used for various estimations.
Lipid Analysis
Lipids in plasma and tissues were extracted by the method
of Folch and colleagues [10]. Total lipids were extracted with
chloroform methanol mixture 2:1 (v/v) after homogenizing the
tissue. Aliquots of the lipid extracts were evaporated to dryness
and used for the estimation of lipids. Estimation of cholesterol,
TGs, phospholipids, FFAs, and concentration of cholesterol in
plasma lipoproteins were carried out following the procedures
described earlier [11].
Lipoprotein lipase (LPL) was assayed in plasma by the
method of Korn [12]. Lecithin cholesterol acyl transferase
(LCAT) was assayed in plasma by the method of Hitz and
colleagues [13]. Hydroxymethylglutaryl–coenzyme A (HMG-
CoA) reductase activity was measured by the method of Rao
and Ramakrishnan [14].
Statistical Analysis
Values are expressed as means ± SD. Data was analysed
using one-way analysis of variance (ANOVA) followed by
Duncan’s multiple range test (DMRT). A value of P <. 05
was considered statistically signiﬁcant.
RESULTS
The plasma lipid concentrations were found to be signiﬁ-
cantly increased in rats fed high fructose (Figure 1). Rats si-
multaneously treated with LA along with fructose (FRU+LA)
showed signiﬁcant reductions as compared to fructose-treated
rats.
Concentrationsoflipidsinliver,kidney,andskeletalmuscle
of control and experimental animals are given in Figures 2, 3,
and 4, respectively. TG, cholesterol, and FFA concentrations
were signiﬁcantly increased in fructose-fed rats as compared to
normalrats.Thephospholipidconcentrationsweresigniﬁcantly
decreased in fructose-fed rats. LA administration brought the
concentrations of lipid constituents in tissues to near normal in
fructose-treated rats.
Table2summarizesthedistributionofcholesterolinplasma
lipoprotein fractions. The concentrations of VLDL-cholesterol
(VLDL-C)andlow-densitylipoproteinLDL-cholesterol(LDL-
C) were signiﬁcantly increased whereas high-density lipopro-
tein cholesterol (HDL-C) was lowered in fructose-fed rats.LIPOIC ACID INFLUENCES LIPID METABOLISM 197
FIGURE 1
Concentration of cholesterol, TG, FFA, and phospholipids in
plasma of the experimental animals. Values are means ± SD
(n = 6 in each group). ∗P <. 05 as compared to control;
#P <. 05 as compared to fructose. CON: control; FRU:
fructose; LA: lipoic acid; Chol: cholesterol; TG: triglycerides;
FFA: free fatty acids; PL: phospholipids.
These alterations were reversed and the cholesterol distribu-
tion in lipoprotein fractions in LA-treated rats was similar to
that of control rats.
The activities of LPL, LCAT in plasma, and HMG-CoA re-
ductase in liver are presented in the Table 3. The activities of
FIGURE 2
Concentration of cholesterol, TG, FFA, and phospholipids in
liver of the experimental animals. Values are means ± SD (n =
6 in each group). ∗P <. 05 as compared to control; #P <. 05
as compared to fructose. CON: control; FRU: fructose; LA:
lipoic acid; Chol: cholesterol; TG: triglycerides; FFA: free
fatty acids; PL: phospholipids.
FIGURE 3
Concentration of cholesterol, TG, FFA, and phospholipids in
kidney of the experimental animals. Values are means ± SD
(n = 6 in each group). ∗P <. 05 as compared to control;
#P <. 05 as compared to fructose. CON: control; FRU:
fructose; LA: lipoic acid; Chol: cholesterol; TG: triglycerides;
FFA: free fatty acids; PL: phospholipids.
LPLandLCATwereloweredinplasmaandliveroffructose-fed
rats. There was an increased activity of HMG-CoA reductase
in fructose-fed group. The activities of these enzymes were re-
stored to baseline control values when rats were treated with
LA.
FIGURE 4
Concentration of cholesterol, TG, FFA, and phospholipids in
muscle of the experimental animals. Values are means ± SD
(n = 6 in each group). ∗P <. 05 as compared to control;
#P <. 05 as compared to fructose. CON: control; FRU:
fructose; LA: lipoic acid; Chol: cholesterol; TG: triglycerides;
FFA: free fatty acids; PL: phospholipids.198 V. THIRUNAVUKKARASU ET AL.
TABLE 2
Distribution of cholesterol in the lipoprotein fractions (mg/dL)
CON FRU FRU + LA CON + LA
HDL-cholesterol 34.8 ± 2.8 28.8 ± 1.5a 31.3 ± 0.8b 35.0 ± 1.8
LDL-cholesterol 29.0 ± 6.0 44.8 ± 11.5a 38.2 ± 6.2b 31.2 ± 6.2
VLDL-cholesterol 18.6 ± 0.8 29.8 ± 1.5a 19.8 ± 0.7b 18.8 ± 0.7
Note. Values are means ± SD of 6 rats from each group. CON = control rats; FRU =
fructose-fed rats; FRU + LA = fructose-fed rats treated with lipoic acid; CON + LA =
control rats treated with lipoic acid.
aSigniﬁcant as compared with control rats (P <. 05) (DMRT).
bSigniﬁcant as compared with fructose-fed rats (P <. 05) (DMRT).
LAadministrationtonormalratsdidnotproducesigniﬁcant
alterations in the enzyme activities or lipid components.
DISCUSSION
Lipid changes observed in fructose-treated rats were ele-
vated levels of cholesterol, TGs, FFAs, and phospholipids in
plasma. HDL-C was decreased whereas there was a signiﬁ-
cant increase in LDL-C and VLDL-C. Accumulation of chole-
strol, TGs, and FFAs, was observed in tissues. These ﬁnd-
ings are consistent with our previous reports [3, 11] and with
those of other investigators [15, 16]. Induction of lipogenic en-
zyme HMG-CoA reductase and alterations in lipid transport
enzymes are also noticed in the present study. Feeding a high-
fructose diet to diabetic rats produces an increase in activity of
HMG-CoA reductase and addition of fructose to cultured rat
hepatocytes increases HMG-CoA reductase by approximately
3-fold [17].
We have previously reported that fructose feeding induces
hyperinsulinemia and insulin resistance [18]. The elevated TG
concentrations can be associated with impaired insulin action.
Biegerandcolleagues[19]haveshowntheincreaseinbloodTG
TABLE 3
Activities of lipoprotein lipase (LPL) and lecithin cholesterol acyl transferase (LCAT)
in plasma and hydroxymethylglutaryl (HMG)-CoA reductase in liver
CON FRU FRU + LA CON + LA
LCAT 75.3 ± 2.2 64.1 ± 2.3a 72.8 ± 1.8b 74.2 ± 1.2
(µmoles of cholesterol/hr/L)
LPL 5.7 ± 0.6 4.8 ± 0.5a 5.3 ± 0.2b 5.8 ± 0.7
(µmoles of glycerol liberated/hr/L)
HMG-CoA reductase 3.1 ± 0.13 2.1 ± 0.2a 3.1 ± 0.1b 3.1 ± 0.1
(Ratio of HMG-CoA to mevalonate)c
Note. Values are means ± SD of 6 rats from each group. CON = control rats; FRU = fructose-fed rats; FRU +
LA = fructose-fed rats treated with lipoic acid; CON + LA = control rats treated with lipoic acid.
aSigniﬁcant as compared with control rats (P <. 05) (DMRT).
bSigniﬁcant as compared with fructose-fed rats (P <. 05) (DMRT).
cLower ratio indicates higher enzyme activity and vice versa.
concentrations can decrease insulin sensitivity by reducing the
number of insulin receptors. A causative link between elevated
circulating TGs and impaired insulin action was observed in
fructose-fed rats by Thorburn and colleagues [16].
Increased TG levels in fructose-fed rats might be attributed
both to the overproduction of hepatic VLDL-TG and impaired
peripheral clearance. Increased hepatic TG production might
result from the conversion of fructose carbon into glycerol-3-
phosphate, a precursor of lipid synthesis [2] or from increased
esteriﬁcation of circulatory nonesteriﬁed fatty acids. Several
authors have reported increased hepatic lipogenesis as a conse-
quence of dietary fructose [20, 21].
FFAs serve as important substrates for hepatic TG synthe-
sis and high concentrations could lead to hypertriglyceridemia.
Fiebigandcolleagues[22]evidencedthathigh-fructosefeeding
may increase the availability of long-chain fatty acids required
for synthesis of TGs by up-regulating the hepatic lipogenic en-
zymes, including hepatic fatty acid synthase and acetyl-CoA
carboxylase. Furthermore, the acute inhibitory effect of in-
sulin on hepatic VLDL secretion is modiﬁed by the ambient
plasma FFA concentration. Signiﬁcant reduction in the activity
ofLPLcouldbeanotherreasonforhypertriglyceridemia.AcuteLIPOIC ACID INFLUENCES LIPID METABOLISM 199
administration of glucose elevates adipose tissue LPL activity
whereas fructose fails to increase adipose tissue LPL activity
[23].
The lowered HDL-C concentration in fructose-fed rats can
be attributed to the decreased LPL and LCAT activities in
plasma. LCAT, the enzyme that catalyzes esteriﬁcation of
cholesterolwithFFAs,alongwithLPLisresponsibleforHDL-
C synthesis. It plays an important role in cholesterol and TG
transportandmetabolism.ThedecreasedactivityofLCATindi-
catesimpairmentinHDL-CsynthesisaswellasTGmetabolism
in fructose-fed rats. The effect of fructose feeding on LCAT,
LPL,andHMG-CoAreductaseproduceschangesinlipidcom-
ponents, mainly in the concentrations of cholesterol, TGs,
HDL-C, and VLDL-C. Hallfrisch and colleagues [24] demon-
strated higher plasma cholesterol and LDL-C concentration in
healthy and hyperinsulinemic subjects after 4 weeks of high-
fructose diet.
The reduction in the activity of LPL, an insulin-sensitive
enzyme, in fructose-fed rats can be ascribed to the insulin re-
sistance induced by fructose. Fructose feeding can lead to a de-
crease in the ability of insulin to stimulate the activity of LPL
[25]. Hepatic lipase, another key enzyme of lipid metabolism
subjecttoregulationbyinsulin,isabundantinsubluminalextra-
cellular matrix of liver and hydrolyses TGs and phospholipids
fromlipoprotein.Itcouldbepossiblethattheactivityofhepatic
lipase is blocked in these rats due to hepatic insulin resistance.
HighplasmaFFAconcentrationimpairstheactionofinsulin
on glucose disposal via substrate competition in the glucose-
FFA cycle. Conversely, diminished insulin-stimulated glucose
disposalcouldleadtoimpairedFFAreesteriﬁcationandthereby
to higher circulating FFA concentrations. Elevated concentra-
tions of plasma FFAs may play a key role in the pathogenesis
of type 2 diabetes by impairing peripheral glucose utilization
and by promoting hepatic glucose overproduction [26]. These
datasuggestthattheactionofinsulinonFFAmetabolismisim-
paired in hyperinsulinemia/insulin resistance state. This could
explain higher TG concentrations in fructose-fed rats in the
present study.
Fructose facilitates oxidative damage in tissues [27]. In-
creased plasma phospholipids and their depletion in tissues of
fructose-fedratsmaybeattributedtooxidativestress.Themajor
targetsofdamagingfreeradicalsarethecellularandmembrane
phospholipids[28].Theoxidativetissuedamagecanreleasethe
membrane lipids such as FFAs and phospholipids into blood
[29].
Supplementation of LA to rats fed high-fructose diet miti-
gated these alterations. The levels of plasma and tissue lipids
were lowered signiﬁcantly when LA was administered along
with fructose. HDL-C concentration was increased whereas
those of LDL-C and VLDL-C were decreased.
TheseeffectsofLAonlipidmetabolismmayberelatedtoits
effect on glucose utilisation. LA increases glucose disposal, in-
sulin sensitivity, and insulin action in fructose-treated rats [30].
This could result in efﬁcient regulation of the key enzymes of
lipid metabolism measured in the present study by normaliz-
ing the circulatory lipid concentrations. Lowering of plasma
TG concentrations may be attributed to the reduced availabil-
ity of the precursor FFAs and to enhanced peripheral tissue
clearance through increased LPL activity. The rise in plasma
concentrations of HDL-C in LA-treated fructose rats may be
due to delayed clearance and increased synthesis of HDL con-
stituents. Moreover stimulation of LPL leads to a rise in HDL
production and reduction in VLDL constituents [31]. Mainte-
nance of ambient levels of phospholipids in plasma and tissues
ofLA-treatedfructoseratscouldbeduetoantioxidantproperty
exertedbyLA.LAquenchesreactiveoxygenspeciesthatcould
act on membranes of the biological systems [5].
LA is reported to favorably inﬂuence the plasma and tis-
sue concentrations of lipids during Adriamycin-induced hyper-
lipidemia in rats [8]. LA has also marked effects in lowering
vascular hemostatic and lipid risk factors in the streptozotocin-
diabetic rats [32].
TheresultsofthepresentstudysuggestthatLAhasmodula-
toryeffectsonlipidmetabolisminfructose-fedinsulin-resistant
rats. Risk factors for cardiovascular disease, such as dyslipi-
demia, hypertension, and glucose intolerance, tend to cluster
within individuals and insulin resistance is a common fea-
ture in these conditions. A parallel between this nutritional-
experimental model and the multimetabolic syndrome called
syndrome X has been postulated by Reaven [33]. The present
ﬁndings show that LA may have implications for the treatment
of dyslipidemia associated with insulin resistance.
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